Medindia
Medindia LOGIN REGISTER
Advertisement

The Valeant Dermatology ASPIRE HIGHER Scholarship Program Names Nine Undergraduate and Graduate Student Winners

Thursday, August 4, 2016 Lifestyle and Wellness News
Advertisement
$10,000 Scholarships Recognize Students who have Faced the Challenges of Living with a Dermatologic Condition

BRIDGEWATER, N.J., Aug. 4, 2016 /PRNewswire/ -- With many students soon heading back to college campuses around the nation, Valeant Dermatology, a division of Valeant Pharmaceuticals North America LLC, today announced the winners of its ASPIRE HIGHER Scholarship Program.  Nine undergraduate and graduate students were selected from a pool of 970 applicants and awarded up to $10,000 each toward tuition expenses for the coming school year.
Advertisement

The winners were chosen based on a written essay describing the impact a dermatologic condition had on their life and the role their healthcare practitioner played in treating their condition.  Three scholarships were awarded in each of three categories: Undergraduate Scholar Awards for those pursuing and an undergraduate degree, Graduate Scholar Awards for students pursuing a graduate degree and Today's Woman Scholar Awards for students who are mothers and pursuing any higher-education degree.   
Advertisement

"Valeant congratulates the winners of this year's scholarship program and thanks all of the applicants for sharing their personal stories of how their lives were affected by their skin condition and the clinician who helped with its treatment," said Eric Abramson, Valeant Dermatology's Senior Vice President and General Manager. "We are proud to support these outstanding and dedicated students in achieving their academic ambitions."

The nine winners will attend the following schools of higher education this year:

Undergraduate student winners:

  • Colin Axnér of Tracy, California will attend the University of California, Berkeley
  • Courtney Sayre of Marcellus, New York will attend the State University of New York, Oswego
  • Jordyn Schara of North Freedom, Wisconsin will attend the University of Wisconsin, Madison
Graduate student winners:

  • Neela Persad of Homestead, Florida will attend Columbia University
  • Stephanie Laning of Worth, Illinois will attend Utah State University
  • Joshua Haag of New York, New York will attend Long Island University, Brooklyn Campus
  • Today's Woman Scholar winners:
  • Siobhan Reagan of Front Royal, Virginia is currently attending Lord Fairfax Community College
  • Farah Sayyed-Unas of Bloomingdale, New Jersey will attend Rutgers University
  • Laura Lasseter of Flowery Branch, Georgia will attend the University of Georgia Graduate School
"There were so many compelling stories and deserving applicants that it was extremely difficult to choose the winners," said Linda Stein Gold, M.D., Director, Dermatology Clinical Research, Henry Ford Health System, one of three judges of the scholarship awards.  "It's truly inspiring to see how they dealt with their condition and turned challenging circumstances into something positive in their lives." 

Enrollment information for the 2017 scholarship program will be announced early next year.  For more information, visit www.ValeantAspireHigher.com.

About Valeant Pharmaceuticals North America, LLC

Valeant Pharmaceuticals North America LLC, is a specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of prescription dermatology, eye health, consumer healthcare and other pharmaceutical products. More information about Valeant can be found at www.valeant.com.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/the-valeant-dermatology-aspire-higher-scholarship-program-names-nine-undergraduate-and-graduate-student-winners-300308436.html

SOURCE Valeant Pharmaceuticals North America LLC

Sponsored Post and Backlink Submission


Latest Press Release on Lifestyle and Wellness News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close